13F
← All fund report cards

WOLVERINE ASSET MANAGEMENT LLC

13F equity value
$6.4B
Positions
1,275
Top 10 concentration
23.0%
Quarters / total new picks
32 / 2,764
13F equity value over time
$0M$5B$11B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 40.6% of quarters (excess t = -1.96, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-1.4%
t-stat
-1.96
Quarterly win rate
41%
Annualized excess
-4.5%
$1 → follow vs universe
$1.49 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.03220180630: follow 0.98920180930: follow 1.02120181231: follow 1.00120190331: follow 0.99720190630: follow 1.08420190930: follow 1.13320191231: follow 0.86320200331: follow 1.01920200630: follow 1.13020200930: follow 1.36820201231: follow 1.43720210331: follow 1.43720210630: follow 1.48820210930: follow 1.35920211231: follow 1.11120220331: follow 1.11320220630: follow 0.96520220930: follow 1.02120221231: follow 0.98420230331: follow 1.01520230630: follow 0.99120230930: follow 1.09820231231: follow 1.21020240331: follow 1.17820240630: follow 1.34920240930: follow 1.35420241231: follow 1.26920250331: follow 1.34820250630: follow 1.33120250930: follow 1.43820251231: follow 1.492 0.79 1.52 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 1275 · 2026 Q1

Ticker Value Weight QoQ
BABA $342M
5.3%
HOLD
BBIO $148M
2.3%
ADD
MSTR $146M
2.3%
ADD
SMCI $133M
2.1%
HOLD
ASND $116M
1.8%
HOLD
PCG $111M
1.7%
HOLD
TCOM $110M
1.7%
HOLD
ALB $110M
1.7%
ADD
JD $109M
1.7%
HOLD
COIN $102M
1.6%
HOLD
RIVN $99M
1.6%
HOLD
LI $90M
1.4%
HOLD
TMDX $86M
1.3%
ADD
ON $82M
1.3%
TRIM
PPL $77M
1.2%
NEW
MSTR $76M
1.2%
TRIM
MSTR $75M
1.2%
NEW
ITRI $72M
1.1%
ADD
GWRE $71M
1.1%
NEW
WK $65M
1.0%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.